RULES FOR PRESENTERS
RULES FOR PRESENTERS
Rules for presenters
Patient Privacy / Clinical Photography
Photographs should at all times protect the privacy and identity of the subject. Eyes should be blacked out. The source of the photographs must also be declared if not the property of the presenter. This is to prevent the use of photographic material without permission.
Copyright and Publication of Abstracts
Submission of an abstract implies that it has been approved by all listed authors.
The Scientific Programming Committee reserves the right to make the final decision concerning the form of presentation.
As part of the submission, the author grants EADV the exclusive right to first publish the abstract, and thereafter a non-exclusive right to publish, reproduce, distribute, display and store the abstract worldwide in all forms (including on the EADV website), formats and media now known or as developed in the future, including print, electronic and digital forms. For the avoidance of doubt, “electronic and digital forms” shall include but shall not be limited to databases, USB and forms accessible via electronic and digital networks, wireless transmission and communication systems. The author also grants EADV the exclusive right to retain income resulting from the above-mentioned publications by EADV. No fee shall be paid to the author by EADV for the license granted herein. The author will retain copyright of his or her abstract, including the pertaining moral rights. However, the author shall only reuse, reproduce or post the abstract with acknowledgment to the initial and first publication or presentation at an EADV event, and therefore reference the name of the EADV event and the date.
The License of Copyright Use between EADV and the author is governed and construed in accordance with the laws of Switzerland.
Accepted abstracts will be published as a supplement of EADV, on our official website and on the abstract USB.
Speaker Disclosure of Potential Conflicts of Interest
All speakers must disclose any possible conflict of interest before accepting an invitation. Speakers must also explain any conflicting interests to the audience at the start of the lecture. A slide indicating conflict of interest or a confirmation if there is none, should also be shown on the screen after the title of presentation. If no announcement is made, the chairperson shall ask for any relevant disclosure at the end of the presentation. The EADV Scientific Programming Committee requires that all presentations be as free of commercial bias as possible and that any information on commercial products or services be based on already generally accepted medical thinking. It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabeled or research-associated commercial products should disclose this situation to session attendees.